Dexxience (betrixaban)
- Region
- 🇪🇺 EU
- Active substance
- betrixaban
- Company
- Portola Pharma UK Limited
- Status
- Refused
- Therapeutic area
- Venous Thromboembolism
- CHMP opinion
- Thu 26 Jul 2018
- Application
- EMEA/H/C/004309
- ATC
- B01AF
- Official record
- www.ema.europa.eu
Indication
Prevention of venous thromboembolism
Regulatory milestones
No milestones recorded in the last year.
Follow Dexxience
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.